Clinical Trial

Yunzhi Essence to Improve the Quality of Life of Patients With Advanced Stage of Cancer

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
A randomized, double-blinded, placebo-controlled clinical trial using a Chinese Medicine 'Coriolus Versicolor for improving the quality of life of patients with advanced-stage cancer. Subjects will be randomized into a treatment group or placebo group for 6 months.
Protocol Amendment History 3 changes
critical Recruitment opened 2026-07-31
notable Primary completion pushed: 2026-03-31 -> 2027-03-31 2026-07-31
minor Completion pushed: 2026-09-30 -> 2027-09-30 2026-07-31
Trial Details
NCT Number NCT05754801
Lead Sponsor Chinese University of Hong Kong
Conditions Cancer, Palliative Care
Enrollment 172 participants
Start Date 2024-01-05
Primary Completion 2027-03-31 (estimated)
Study Completion 2027-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-30